MTHFR 677C>T and ACE D/I polymorphisms in migraine: A systematic review and meta-analysis

Headache

Volumn 50, Issue 4, 2010, Pages 588-599

  Schürks, Markus ^a,e   Rist, Pamela M ^a,b   Kurth, Tobias ^a,b,c,d  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c INSERM   (France)

^d SORBONNE UNIVERSITÉ   (France)

^e UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

ACE D I polymorphism; Meta analysis; Migraine; MTHFR 677C>T polymorphism

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); DIPEPTIDYL CARBOXYPEPTIDASE;

ALLELE; ARTICLE; CAUCASIAN; GENE FREQUENCY; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; PRIORITY JOURNAL; RISK FACTOR; SENSITIVITY ANALYSIS;

CONTINENTAL POPULATION GROUPS; DNA MUTATIONAL ANALYSIS; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GENOTYPE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIGRAINE DISORDERS; ODDS RATIO; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC;

EID: 77950532025     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2009.01570.x     Document Type: Article

References (40)

1. Haut SR, Bigal ME, Lipton RB. Chronic disorders with episodic manifestations: Focus on epilepsy and migraine. Lancet Neurol. 2006 5 : 148 157.
2. Pietrobon D, Striessnig J. Neurobiology of migraine. Nat Rev Neurosci. 2003 4 : 386 398.
3. Tietjen EG. Migraine and ischaemic heart disease and stroke: Potential mechanisms and treatment implications. Cephalalgia. 2007 27 : 981 987.
4. Vanmolkot FH, Van Bortel LM, de Hoon JN. Altered arterial function in migraine of recent onset. Neurology. 2007 68 : 1563 1570.
5. Kurth T, Gaziano JM, Cook NR, Logroscino G, Diener HC, Buring JE. Migraine and risk of cardiovascular disease in women. JAMA. 2006 296 : 283 291.
6. Rubino E, Ferrero M, Rainero I, Binello E, Vaula G, Pinessi L. Association of the C677T polymorphism in the MTHFR gene with migraine: A meta-analysis. Cephalalgia. 2009 29 : 818 825.
7. de Tommaso M, Difruscolo O, Sardaro M, et al. Influence of MTHFR genotype on contingent negative variation and MRI abnormalities in migraine. Headache. 2007 47 : 253 265.
8. Pezzini A, Grassi M, Del Zotto E, et al. Migraine mediates the influence of C677T MTHFR genotypes on ischemic stroke risk with a stroke-subtype effect. Stroke. 2007 38 : 3145 3151.
9. Schürks M, Zee RY, Buring JE, Kurth T. Interrelationships among the MTHFR 677C>T polymorphism, migraine, and cardiovascular disease. Neurology. 2008 71 : 505 513.
10. Ferro A, Castro MJ, Lemos C, et al. The C677T polymorphism in MTHFR is not associated with migraine in Portugal. Dis Markers. 2008 25 : 107 113.
11. Joshi G, Pradhan S, Mittal B. Role of the ACE ID and MTHFR C677T polymorphisms in genetic susceptibility of migraine in a north Indian population. J Neurol Sci. 2009 277 : 133 137.
12. Kara I, Ozkok E, Aydin M, et al. Combined effects of ACE and MMP-3 polymorphisms on migraine development. Cephalalgia. 2007 27 : 235 243.
13. Lea RA, Ovcaric M, Sundholm J, Solyom L, Macmillan J, Griffiths LR. Genetic variants of angiotensin converting enzyme and methylenetetrahydrofolate reductase may act in combination to increase migraine susceptibility. Brain Res Mol Brain Res. 2005 136 : 112 117.
14. Lin JJ, Wang PJ, Chen CH, Yueh KC, Lin SZ, Harn HJ. Homozygous deletion genotype of angiotensin converting enzyme confers protection against migraine in man. Acta Neurol Taiwan. 2005 14 : 120 125.
15. Kowa H, Fusayasu E, Ijiri T, et al. Association of the insertion/deletion polymorphism of the angiotensin I-converting enzyme gene in patients of migraine with aura. Neurosci Lett. 2005 374 : 129 131.
16. Paterna S, Di Pasquale P, D'Angelo A, et al. Angiotensin-converting enzyme gene deletion polymorphism determines an increase in frequency of migraine attacks in patients suffering from migraine without aura. Eur Neurol. 2000 43 : 133 136.
17. Cakmak EA, Cataloluk O, Yoldas T, et al. Migraine and angiotensin-converting enzyme association in Turkish patients. Pain Clin. 2003 15 : 473 477.
18. Schürks M, Zee RYL, Buring JE, Kurth T. ACE D/I polymorphism, migraine, and cardiovascular disease in women. Neurology. 2009 72 : 650 656.
19. Tronvik E, Stovner LJ, Bovim G, et al. Angiotensin-converting enzyme gene insertion/deletion polymorphism in migraine patients. BMC Neurol. 2008 8 : 4.
20. Sagoo GS, Little J, Higgins JP. Systematic reviews of genetic association studies. PLoS Med. 2009 6 : e28.
21. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003 327 : 557 560.
22. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994 50 : 1088 1101.
23. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997 315 : 629 634.
24. Bassi B, Parodi E, Messina M, et al. Screening for genetic and acquired thrombophilia in a cohort of young migrainous patients. J Headache Pain. 2003 4 : 138 145.
25. Bottini F, Celle ME, Calevo MG, et al. Metabolic and genetic risk factors for migraine in children. Cephalalgia. 2006 26 : 731 737.
26. Kara I, Sazci A, Ergul E, Kaya G, Kilic G. Association of the C677T and A1298C polymorphisms in the 5,10 methylenetetrahydrofolate reductase gene in patients with migraine risk. Brain Res Mol Brain Res. 2003 111 : 84 90.
27. Kaunisto MA, Kallela M, Hamalainen E, et al. Testing of variants of the MTHFR and ESR1 genes in 1798 Finnish individuals fails to confirm the association with migraine with aura. Cephalalgia. 2006 26 : 1462 1472.
28. Kowa H, Yasui K, Takeshima T, Urakami K, Sakai F, Nakashima K. The homozygous C677T mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for migraine. Am J Med Genet. 2000 96 : 762 764.
29. Lea RA, Ovcaric M, Sundholm J, MacMillan J, Griffiths LR. The methylenetetrahydrofolate reductase gene variant C677T influences susceptibility to migraine with aura. BMC Med. 2004 2 : 3.
30. Magis D, Allena M, Coppola G, Di Clemente L, Gerard P, Schoenen J. Search for correlations between genotypes and electrophysiological patterns in migraine: The MTHFR C677T polymorphism and visual evoked potentials. Cephalalgia. 2007 27 : 1142 1149.
31. Oterino A, Valle N, Bravo Y, et al. MTHFR T677 homozygosis influences the presence of aura in migraineurs. Cephalalgia. 2004 24 : 491 494.
32. Oterino A, Valle N, Pascual J, et al. Thymidylate synthase promoter tandem repeat and MTHFD1 R653Q polymorphisms modulate the risk for migraine conferred by the MTHFR T677 allele. Brain Res Mol Brain Res. 2005 139 : 163 168.
33. Paterna S, Di Pasquale P, Cottone C, et al. Migraine without aura and ACE-gene deletion polymorphism: Is there a correlation? Preliminary findings. Cardiovasc Drugs Ther. 1997 11 : 603 604.
34. Scher AI, Terwindt GM, Verschuren WM, et al. Migraine and MTHFR C677T genotype in a population-based sample. Ann Neurol. 2006 59 : 372 375.
35. Tietjen GE, Herial NA, Utley C, White L, Yerga-Woolwine S, Joe B. Association of von Willebrand factor activity with ACE I/D and MTHFR C677T polymorphisms in migraine. Cephalalgia. 2009 29 : 960 968.
36. Todt U, Freudenberg J, Goebel I, et al. MTHFR C677T polymorphism and migraine with aura. Ann Neurol. 2006 60 : 621 622 author reply 622-623.
37. Fusayasu E, Kowa H, Takeshima T, Nakaso K, Nakashima K. Increased plasma substance P and CGRP levels, and high ACE activity in migraineurs during headache-free periods. Pain. 2007 128 : 209 214.
38. Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders: 2nd edition. Cephalalgia. 2004 24 (Suppl. 1 9 160.
39. Launer LJ, Terwindt GM, Ferrari MD. The prevalence and characteristics of migraine in a population-based cohort: The GEM study. Neurology. 1999 53 : 537 542.
40. Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: Data from the American Migraine Study II. Headache. 2001 41 : 646 657.